A previous study investigating the pulmonary endothelial cell model of acute injury induced by LPS demonstrated that both mesenchymal stem cells and S1P can alleviate ALI via regulation of S1P receptors and SphK, suggesting that S1P acts as a novel therapeutic strategy to improve clinical outcome in severe malaria [29]. This evidence concerns the gene SPHK1 and malaria.